Ovid Therapeutics Inc. — All Filings
493 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-17-031370 | May 10, 2017 | — |
| 8-K | FORM 8-K | 0001193125-17-166080 | May 10, 2017 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-17-031377 | May 10, 2017 | — |
| 424B4 | 424B4 | 0001193125-17-160655 | May 5, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030067 | May 4, 2017 | — |
| EFFECT | — | 9999999995-17-001185 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030084 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030080 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030078 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030075 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030073 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030070 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030068 | May 4, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-17-030065 | May 4, 2017 | — |
| CERTNAS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-17-005952 | May 4, 2017 | — |
| CT ORDER | — | 9999999997-17-005940 | May 4, 2017 | — |
| 8-A12B | 8-A12B | 0001193125-17-157155 | May 4, 2017 | — |
| S-1/A | AMENDMENT NO. 4 TO FORM S-1 | 0001193125-17-155688 | May 3, 2017 | — |
| CORRESP | — | 0001193125-17-153906 | May 2, 2017 | — |
| S-1/A | AMENDMENT NO. 3 TO FORM S-1 | 0001193125-17-152270 | May 2, 2017 | — |
| CORRESP | — | 0001193125-17-153918 | May 2, 2017 | — |
| S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001193125-17-135563 | Apr 25, 2017 | — |
| S-1/A | S-1/A | 0001193125-17-127476 | Apr 18, 2017 | — |
| CORRESP | — | 0001193125-17-125408 | Apr 17, 2017 | — |
| S-1 | FORM S-1 | 0001193125-17-118846 | Apr 10, 2017 | — |
| DRSLTR | — | 0000950123-17-002970 | Mar 20, 2017 | — |
| DRS/A | — | 0000950123-17-002968 | Mar 20, 2017 | — |
| UPLOAD | — | 0000000000-17-007311 | Mar 6, 2017 | — |
| DRS | — | 0000950123-17-000739 | Feb 3, 2017 | — |
| D | — | 0001636651-17-000001 | Jan 20, 2017 | — |
| D | — | 0001140361-15-032597 | Aug 18, 2015 | — |
| D | — | 0001140361-15-012509 | Mar 18, 2015 | — |